Progyny will announce Q3 2025 financial results on November 6, 2025, followed by a conference call.
Quiver AI Summary
Progyny, Inc. will announce its financial results for the third quarter of 2025 on November 6, following the close of the market. A conference call is scheduled for 4:45 PM ET that same day, where the company will discuss the results. Participants can join the call using specific dial-in numbers and passcodes, with an audio replay available until November 13. Progyny, a leader in women's health and family building solutions, is dedicated to helping individuals achieve their family and health goals through comprehensive support and access to specialized care. The company is recognized for its innovation and workplace culture by various prestigious organizations. More information can be found on its website.
Potential Positives
- Progyny will report its financial results for Q3 2025, providing insights into the company's performance and growth trajectory.
- The company has positioned itself as a trusted leader in the women's health and family building solutions sector, which is a vital and expanding market.
- Progyny has received multiple prestigious recognitions, including being named a TIME100 Most Influential Company and a CNBC Disruptor 50, highlighting its innovation and impact in the industry.
- The upcoming conference call and accessible audio replay demonstrate the company's commitment to transparency and communication with investors and stakeholders.
Potential Negatives
- The press release does not provide any specific financial guidance or performance expectations ahead of the upcoming results, which may raise concerns among investors about the company's transparency and future outlook.
- The upcoming conference call may imply that the company has significant information to disclose, which could indicate underlying issues if their results are not as positive as expected.
- There is no mention of any new initiatives or strategies being implemented to address potential challenges, which may signal a lack of proactive measures in a competitive market.
FAQ
When will Progyny report its financial results?
Progyny will report its financial results for the quarter ended September 30, 2025, on November 6, 2025.
What time is the conference call for Progyny's financial results?
The conference call will be held at 4:45 P.M. Eastern Time on November 6, 2025.
How can I access the conference call?
U.S. participants can dial 1.866.825.7331 and international participants can call 1.973.413.6106 to join the conference call.
Will there be an audio replay of Progyny's conference call?
Yes, an audio replay will be available until November 13, 2025, using the specified access numbers and passcode.
Where can I find more information about Progyny?
More information is available on Progyny's official website under the Events and Presentations section at http://investors.progyny.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PGNY Insider Trading Activity
$PGNY insiders have traded $PGNY stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PGNY stock by insiders over the last 6 months:
- ALLISON SWARTZ (EVP, GC) has made 0 purchases and 2 sales selling 2,997 shares for an estimated $69,152.
- CHERYL SCOTT sold 2,675 shares for an estimated $59,037
- KEVIN K GORDON sold 2,500 shares for an estimated $55,087
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PGNY Hedge Fund Activity
We have seen 155 institutional investors add shares of $PGNY stock to their portfolio, and 145 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- THRIVENT FINANCIAL FOR LUTHERANS removed 3,342,347 shares (-98.3%) from their portfolio in Q2 2025, for an estimated $73,531,634
- BLACKROCK, INC. added 1,813,119 shares (+14.2%) to their portfolio in Q2 2025, for an estimated $39,888,618
- VANGUARD GROUP INC added 1,252,671 shares (+14.5%) to their portfolio in Q2 2025, for an estimated $27,558,762
- MILLENNIUM MANAGEMENT LLC removed 876,142 shares (-67.2%) from their portfolio in Q2 2025, for an estimated $19,275,124
- CITADEL ADVISORS LLC removed 739,200 shares (-69.3%) from their portfolio in Q2 2025, for an estimated $16,262,400
- RENAISSANCE TECHNOLOGIES LLC added 727,800 shares (+inf%) to their portfolio in Q2 2025, for an estimated $16,011,600
- FMR LLC added 605,082 shares (+14.7%) to their portfolio in Q2 2025, for an estimated $13,311,804
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PGNY Analyst Ratings
Wall Street analysts have issued reports on $PGNY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 08/08/2025
- Leerink Partners issued a "Outperform" rating on 07/08/2025
To track analyst ratings and price targets for $PGNY, check out Quiver Quantitative's $PGNY forecast page.
$PGNY Price Targets
Multiple analysts have issued price targets for $PGNY recently. We have seen 5 analysts offer price targets for $PGNY in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Anne Samuel from JP Morgan set a target price of $25.0 on 08/26/2025
- Richard Close from Canaccord Genuity set a target price of $23.0 on 08/20/2025
- Sarah James from Cantor Fitzgerald set a target price of $28.0 on 08/08/2025
- Jailendra Singh from Truist Securities set a target price of $27.0 on 07/17/2025
- Michael Cherny from Leerink Partners set a target price of $28.0 on 07/08/2025
Full Release
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the market on Thursday, November 6, 2025.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Thursday, November 13, 2025 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com .
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans, and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
[email protected]
Media:
Alexis Ford
[email protected]
